| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.5 |